T-cell vaccination technology for the treatment of multiple sclerosis.
THE WOODLANDS, Texas, USA—
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved in the development ... more »
|
|||||
|
Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
This Month
|
Wednesday, June 27
T-cell vaccination technology for the treatment of multiple sclerosis.
by
All About MS
on Wed 27 Jun 2007 09:16 AM CST
|
||||